Suppr超能文献

HIV-1 Vpr 上调激活型 NKG2D 受体配体的表达并促进 NK 细胞介导的杀伤。

HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.

机构信息

Institut de Recherches Cliniques de Montréal, QC, Canada.

出版信息

Blood. 2010 Feb 18;115(7):1354-63. doi: 10.1182/blood-2009-08-237370. Epub 2009 Dec 14.

Abstract

HIV up-regulates cell-surface expression of specific ligands for the activating NKG2D receptor, including ULBP-1, -2, and -3, but not MICA or MICB, in infected cells both in vitro and in vivo. However, the viral factor(s) involved in NKG2D ligand expression still remains undefined. HIV-1 Vpr activates the DNA damage/stress-sensing ATR kinase and promotes G(2) cell-cycle arrest, conditions known to up-regulate NKG2D ligands. We report here that HIV-1 selectively induces cell-surface expression of ULBP-2 in primary CD4(+) T lymphocytes by a process that is Vpr dependent. Importantly, Vpr enhanced the susceptibility of HIV-1-infected cells to NK cell-mediated killing. Strikingly, Vpr alone was sufficient to up-regulate expression of all NKG2D ligands and thus promoted efficient NKG2D-dependent NK cell-mediated killing. Delivery of virion-associated Vpr via defective HIV-1 particles induced analogous biologic effects in noninfected target cells, suggesting that Vpr may act similarly beyond infected cells. All these activities relied on Vpr ability to activate the ATR-mediated DNA damage/stress checkpoint. Overall, these results indicate that Vpr is a key determinant responsible for HIV-1-induced up-regulation of NKG2D ligands and further suggest an immunomodulatory role for Vpr that may not only contribute to HIV-1-induced CD4(+) T-lymphocyte depletion but may also take part in HIV-1-induced NK-cell dysfunction.

摘要

HIV 上调感染细胞表面表达 NKG2D 激活受体的特定配体,包括 ULBP-1、ULBP-2 和 ULBP-3,但不包括 MICA 或 MICB,无论是在体外还是体内。然而,参与 NKG2D 配体表达的病毒因子仍未确定。HIV-1 Vpr 激活 DNA 损伤/应激感应 ATR 激酶并促进 G2 细胞周期停滞,这些条件已知可上调 NKG2D 配体。我们在此报告 HIV-1 通过一种依赖 Vpr 的过程选择性地上调原代 CD4+T 淋巴细胞表面 ULBP-2 的表达。重要的是,Vpr 增强了 HIV-1 感染细胞对 NK 细胞介导的杀伤的敏感性。引人注目的是,Vpr 本身足以上调所有 NKG2D 配体的表达,从而促进有效的 NKG2D 依赖性 NK 细胞介导的杀伤。通过有缺陷的 HIV-1 颗粒传递病毒相关的 Vpr,在未感染的靶细胞中诱导类似的生物学效应,这表明 Vpr 可能在感染细胞之外也具有类似的作用。所有这些活性都依赖于 Vpr 激活 ATR 介导的 DNA 损伤/应激检查点的能力。总的来说,这些结果表明 Vpr 是 HIV-1 诱导 NKG2D 配体上调的关键决定因素,并进一步表明 Vpr 具有免疫调节作用,不仅可能导致 HIV-1 诱导的 CD4+T 淋巴细胞耗竭,而且还可能参与 HIV-1 诱导的 NK 细胞功能障碍。

相似文献

1
HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.
Blood. 2010 Feb 18;115(7):1354-63. doi: 10.1182/blood-2009-08-237370. Epub 2009 Dec 14.
2
HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.
PLoS Pathog. 2009 Oct;5(10):e1000613. doi: 10.1371/journal.ppat.1000613. Epub 2009 Oct 2.
3
4
6
Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?
Curr Drug Targets. 2016;17(1):54-64. doi: 10.2174/1389450116666150630110329.

引用本文的文献

1
HIV controllers: hope for a functional cure.
Front Immunol. 2025 Feb 25;16:1540932. doi: 10.3389/fimmu.2025.1540932. eCollection 2025.
3
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy.
Immunotherapy. 2025 Feb;17(2):133-145. doi: 10.1080/1750743X.2025.2460965. Epub 2025 Feb 5.
4
Emerging role of natural killer cells in non-AIDS comorbidities during suppressive antiretroviral therapy.
Curr Opin HIV AIDS. 2025 Mar 1;20(2):145-153. doi: 10.1097/COH.0000000000000913. Epub 2024 Dec 26.
5
The Role of Natural Killer Cells and Their Metabolism in HIV-1 Infection.
Viruses. 2024 Oct 9;16(10):1584. doi: 10.3390/v16101584.
7
Harnessing immune cells to eliminate HIV reservoirs.
Curr Opin HIV AIDS. 2024 Mar 1;19(2):62-68. doi: 10.1097/COH.0000000000000840. Epub 2024 Jan 2.
8
Vpr attenuates antiviral immune responses and is critical for full pathogenicity of SIV in rhesus macaques.
iScience. 2023 Oct 26;26(12):108351. doi: 10.1016/j.isci.2023.108351. eCollection 2023 Dec 15.
9
NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?
Front Immunol. 2023 Oct 19;14:1267774. doi: 10.3389/fimmu.2023.1267774. eCollection 2023.

本文引用的文献

2
HIV-1 accessory proteins--ensuring viral survival in a hostile environment.
Cell Host Microbe. 2008 Jun 12;3(6):388-98. doi: 10.1016/j.chom.2008.04.008.
3
Soluble NKG2D ligands: prevalence, release, and functional impact.
Front Biosci. 2008 May 1;13:3448-56. doi: 10.2741/2939.
5
HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.
PLoS Pathog. 2007 Jul;3(7):e85. doi: 10.1371/journal.ppat.0030085.
6
DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest.
J Virol. 2007 Oct;81(19):10822-30. doi: 10.1128/JVI.01380-07. Epub 2007 Jul 11.
8
Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle.
Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11778-83. doi: 10.1073/pnas.0702102104. Epub 2007 Jul 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验